Home>Clinical Trials>Available Clinical Trials

Available Brain Clinical Trials

To inquire about participating in these studies, call 1-877-ASK-RPCI (1-877-275-7724).
E-mail: askrpci@roswellpark.org

(COG ACNS0334) A Phase III Randomized Trial for the Treatment of Newly Diagnosed Supratentorial PNET and High Risk Medulloblastoma in Children < 36 Months Old with Intensive Induction Chemotherapy with Methotrexate Followe...
(COG ACNS0332) Efficacy of Carboplatin Administered Concomitantly with Radiation and Isotretinoin as a Pro-Apoptotic Agent in Other Than Average Risk Medulloblastoma/PNET Patients
(PBMTC ONC-032) High Dose Temozolomide, Thiotepa and Carboplatin with Autologous Stem Cell Rescue (ASCR) Followed by Continuation Therapy with 13-cis-Retinoic Acid in Patients with Recurrent/Refractory Malignant Brain Tumors
Phase 1 Study of Safety, Tolerability and Immunological Effects of SVN53-67/M57-KLH (012410-2) in Patients with Survivin-Positive Malignant Gliomas
(COG ACNS1022) A Phase II Randomized Trial of Lenalidomide (NSC #703813, IND #70116) in Pediatric Patients with Recurrent, Refractory or Progressive Juvenile Pilocytic Astrocytomas and Optic Pathway Gliomas
(COG ACNS0831) Phase III Randomized Trial of Post-Radiation Chemotherapy in Patients with Newly Diagnosed Ependymoma Ages 1 to 21 Years